2024 Surescripts White Coat Award Recognizes 10 Healthcare Technology Leaders in Performance, Innovation and Accuracy

1 year ago

ARLINGTON, Va.--(BUSINESS WIRE)--#HealthIT--Surescripts®, the nation's leading health information network, awarded the 2024 Surescripts White Coat Award™ to 10 healthcare industry…

2024 Surescripts White Coat Award Recognizes 10 Healthcare Technology Leaders in Performance, Innovation and Accuracy

1 year ago

ARLINGTON, Va.--(BUSINESS WIRE)--#HealthIT--Surescripts®, the nation's leading health information network, awarded the 2024 Surescripts White Coat Award™ to 10 healthcare industry…

NervGen Pharma Provides Update on Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury

1 year ago

Target enrollment in the chronic cohort close to completionVancouver, British Columbia--(Newsfile Corp. - September 30, 2024) - NervGen Pharma Corp.…

Study Indicates Significant Radiation Reduction for Breast Cancer Patients

1 year ago

Lumpectomy Patients Received VeraForm® Marker and APBI Therapy for Breast Cancer TreatmentSAN FRANCISCO, CA / ACCESSWIRE / September 30, 2024…

Axis Integrated Mental Health Recognized as Top Startup for Advancing Collaborative Mental Health Care

1 year ago

Top Startup Award Marks a Year of Milestones for Colorado's Leading Mental Health InnovatorWESTMINSTER, CO / ACCESSWIRE / September 30,…

Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1

1 year ago

SAN DIEGO, CA / ACCESSWIRE / September 30, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an…

Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403

1 year ago

CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the…

Sonnet BioTherapeutics Announces Launch of CEO Corner Platform

1 year ago

CEO Corner segments to include additional discussion related to press releases, events, corporate updates and pipeline progress Provides interested parties…

MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS)

1 year ago

Academic group to receive a total of $22 million for the trialLA JOLLA, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) --…